SPH Notice – Fisher Funds Management Limited
Disclosure of beginning to have substantial holding
Section 276, Financial Markets Conduct Act 2013
To NZX
And
To Napier Port Holdings LTD
Date this disclosure made: 16/01/2024
Date on which substantial holding began: 16/01/2024
Substantial product holder(s) giving disclosure
Full name(s): Fisher Funds Management Limited
Summary of substantial holding
Class of quoted voting products: Ordinary Shares
Summary for Fisher Funds Management Limited
For this disclosure,—
(a) total number held in class: 10,305,798
(b) total in class: 199,957,884
(c) total percentage held in class: 5.154%
For last disclosure,—
(a) total number held in class: N/A
(b) total in class: N/A
(c) total percentage held in class: N/A
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure:
Date of change Nature of change
Consideration given in
relation to change
Class and number of
securities affected
Other party,
if known
16/09/2023 to
15/01/2024
On market
purchases
$1,209,612.04
515,316 Ordinary Shares
N/A
16/01/2024 On market
purchases
$1,566,406.25
625,000 Ordinary Shares
N/A
Details after relevant event
Details for Fisher Funds Management Limited
Nature of relevant interest(s): Fisher Funds Management Limited is the registered holder
and non-beneficial owner of these securities. No relevant agreement documentation is
required to be attached as the investment management contract exemption under
regulation 14 applies.
For that relevant interest,—
(a) number held in class: See below.
(b) percentage held in class: See below.
(c) current registered holder(s): See below.
(d) registered holder(s) once transfers are registered: Unknown
No. held in class Percentage held in class Current registered holders
10,305,798 5.154%
TEA Custodians on behalf of the Fisher Institutional
Property and Infrastructure Fund
For a derivative relevant interest, also—
(a) type of derivative: Not applicable
(b) details of derivative: Not applicable
(c) parties to the derivative: Not applicable
(d) if the substantial product holder is not a party to the derivative, the nature of the
relevant interest in the derivative: Not applicable
Additional information
Address(es) of substantial product holder(s): Fisher Funds Management Limited, Level 1,
67-73 Hurstmere Road, Takapuna, Auckland
Contact details: Angela Quirk, A ngela@fisherfunds.co.nz, +64 9 487 2627
Nature of connection between substantial product holders: Fisher Funds Management
Limited is the registered holder and non-beneficial owner of these securities
Name of any other person believed to have given, or believed to be required to give, a
disclosure under the Financial Markets Conduct Act 2013 in relation to the financial
products to which this disclosure relates: Not applicable
Certification
I, Angela Quirk, certify that, to the best of my knowledge and belief, the information
contained in this disclosure is correct and that I am duly authorised to make this disclosure
by all persons for whom it is made.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- FPH — Fisher & Paykel Healthcare Corporation Limited: Ongoing Disclosure Notices – Ordinary Shares2023-10-30
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 30 Octob…”
- FPH — Fisher & Paykel Healthcare Corporation Limited: Ongoing Disclosure Notice – Ordinary Shares2024-02-14
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Fisher & Paykel Healthcare Corporation Limited Date this disclosure made: 14 Febru…”
- NZM — NZME Limited: SPH Notice – Spheria Asset Management Pty Limited2024-03-25
“1 Disclosure of movement of 1% or more in substantial holding or change in nature of relevant interest, or both Sections 277 and 278, Financial Markets Conduct Act 2013 To New Zealand Stock Exchange and Australian Stock Exchange and To NZME Limited (NZM) Relevant eve…”